Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1995
08/23/1995EP0667777A1 Xanthine derivatives for use as diuretics
08/23/1995EP0667776A1 Methods and compositions of (+) doxazosin for the treatment of hypertension
08/23/1995EP0667775A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
08/23/1995EP0667774A1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system.
08/23/1995EP0667773A1 Fibrinogen receptor antagonists
08/23/1995EP0667772A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
08/23/1995EP0667771A1 Antitumour compositions containing taxane derivatives
08/23/1995EP0667770A1 Inhibition of tnf production.
08/23/1995EP0667769A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
08/23/1995EP0667768A1 Use of toremifene for treating sle
08/23/1995EP0607129B1 Methylpiperazinoazepine derivatives, their preparation and use
08/23/1995EP0510167B1 Novel steroidal organic substance crystallization method and compounds thereby obtained
08/23/1995EP0500653A4 Inhibitors of purine nucleoside phosphorylase
08/23/1995EP0297109B1 Process for the preparation of a viscosity-stable antacid composition
08/23/1995EP0252962B1 Regulating retroviral replication, infection, and pathogenesis
08/23/1995CN1107277A Novel compound with platelet aggregation inhibitor activity
08/23/1995CN1107158A Polysubstituted 2-amino-thiazole derivatives
08/23/1995CN1107157A Methods for the treatment of peri-menopausal syndrome
08/23/1995CN1107156A Methods of inhibiting uterine fiberosis
08/23/1995CN1107154A Chloride substituted imidazole derivative
08/23/1995CN1107152A Compound for inhibition of virus HIV of AIDS
08/23/1995CN1107151A Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
08/23/1995CN1107149A 哌嗪衍生物 Piperazine derivatives
08/23/1995CN1107146A A process for preparing a composition containing benzoheterocycles
08/23/1995CN1107145A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
08/23/1995CN1107144A Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
08/23/1995CN1107137A Novel carboxylate derivatives exhibiting phospholipase A2 inhibitery a ctivity
08/23/1995CN1107135A Glutaric acid derivatives and preparation thereof
08/23/1995CN1107043A Methods for inhibiting endometriosis
08/23/1995CN1107042A Inclusion complex
08/23/1995CN1107041A Transmucosal delivery of macromolecular drugs
08/23/1995CN1029541C Nutritional composition and process for its production
08/23/1995CA2141987A1 Organopathy preventing, curing or ameliorating agent
08/22/1995US5444174 Effective on grampositive bacteria
08/22/1995US5444095 Used for treament of hypoxia, ischemia, stroke and trauma; nervous system disorders
08/22/1995US5444091 Method of applying alpha hydroxy acids for treating striae distensae
08/22/1995US5444090 Applying a synthetase inhibitor
08/22/1995US5444089 Neutral lipids from endosperm of Job's tears
08/22/1995US5444085 Methods of inhibiting HIV and inhibiting the activation of HIV
08/22/1995US5444083 Pyrrolidine compound and pharmaceutical use
08/22/1995US5444082 3,9-disubstituted-spiro(5.5)undecanes active on the cardiovascular system, process for their preparation and pharmaceutical composition containing same
08/22/1995US5444081 Treatment of hypertension, congestive heart failure, renal failure, glaucoma
08/22/1995US5444080 Hypotensive agents
08/22/1995US5444077 Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use
08/22/1995US5444076 Pharmaceutical preparation for topical application
08/22/1995US5444073 Method for treating memory impairment
08/22/1995US5444072 Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis
08/22/1995US5444071 Quinoline derivatives and use thereof as angiotensin II antagonists
08/22/1995US5444070 Treating a disease or disorder which is responsive to the inhibition of dopamine reuptake by administering a tropane derivative
08/22/1995US5444069 Imidazo-pyridine angiotensin II antagonists used to treat memory loss
08/22/1995US5444068 Imidazopyridine derivatives as angiotensin II receptor antagonists, pharmaceuticals, and treatment of hypertension therewith
08/22/1995US5444065 Fused cycloalkylimidazopyridines as inducer of interferon α biosynthesis
08/22/1995US5444063 95% free of corresponding beta-L enantiomer; oral or parenteral administeration
08/22/1995US5444062 Quinazolines derivatives for enhancing antitumor activity
08/22/1995US5444061 Antitumor agents
08/22/1995US5444059 Anxiolytic agents
08/22/1995US5444057 For treating bacterial infections
08/22/1995US5444056 Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them
08/22/1995US5444055 17-hydroxyiminomethyl-5-β, 14 β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
08/22/1995US5444053 Method for treating symptoms of Alzheimer's with NADH and NADPH
08/22/1995US5444052 Synergistic mixture with a glycerol ether
08/22/1995US5444051 Erythromycin compounds
08/22/1995US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
08/22/1995US5444042 Method of treatment of neurodegeneration with calpain inhibitors
08/22/1995US5444041 Convertible microemulsion formulations
08/22/1995US5443972 Fermentation of Streptomyces
08/22/1995US5443850 Method for treating symptoms associated with vascular headaches by administering a combination of calcium and vitamin D
08/22/1995US5443848 Administering certain ratios of sodium chloride and sodium acetate; treating hemorrhagic shock
08/22/1995US5443847 Specific detoxification of urushiol with manganese salts
08/22/1995US5443844 Linoleic acid preparations for topical treatment of acne vulgaris
08/22/1995US5443842 Mixed with isopropyl myristate or palmitate and polyethoxy-lated, hydrogenated castor oils
08/22/1995US5443839 Liposomes containing scutellaria extracts
08/22/1995US5443837 Parenterally administering 17-alpha-allyl-4,9,11-estratriene-17beta-ol-3-one to breeding animals
08/22/1995US5443834 Thiamine mixed with beef tallow, coconut oil, perfume and glycerin
08/22/1995US5443833 Pharmaceutical compositions
08/22/1995US5443830 Drink containing mucilaginous polysaccharides and its preparation
08/22/1995US5443829 For enhancing delivery of drugs across mucous membranes of animals
08/22/1995US5443824 Soluble in polyethylene glycol having molecular weight range from 200 to 600; widely used in treatment of connective tissue diseases, inflammatory skin, disorder of keratinization, bullous skin disorder, conjunctiva and leprosy
08/22/1995US5443760 Silicone containing oil-in-water emulsions
08/22/1995CA2142919A1 Hydroxylamines with hypoglycemic activity
08/22/1995CA2032231C Substituted oxophthalazinyl acetic acids and analogs thereof
08/22/1995CA2030077C Azabicyclo amides and esters as 5-ht _receptor antagonists
08/22/1995CA2022516C Saccharide derivatives of protocatechualdehyde
08/22/1995CA2012013C Antitumor antibiotic bmy-41339
08/22/1995CA1336777C Dextro-rotatory enantiomer of methyl alpha-5 (4,5,6,7-tetrahydro (3,2-c) thieno pyridyl) (2-chlorophenyl)-acetate, a process for its preparation and the pharmaceutical compositions containing it
08/22/1995CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives
08/22/1995CA1336762C Method and composition for treating and preventing dry skin disorders
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/19/1995CA2142513A1 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
08/19/1995CA2142315A1 Drug
08/18/1995CA2142647A1 Fungicide 2-imidazoline-5-ones derivatives
08/18/1995CA2115861A1 Stabilization of a prostanoic acid compound
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021927A2 Targeting gene therapy
08/17/1995WO1995021912A1 Non-pathogenic strains of hiv-1
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021856A1 Carbamoylmethylurea derivative
08/17/1995WO1995021845A1 Texaphyrin metal complexes having improved functionalization
08/17/1995WO1995021844A1 5ht2b receptor antagonists condensed indoles
08/17/1995WO1995021843A1 Azacyclic derivatives
1 ... 6991 6992 6993 6994 6995 6996 6997 6998 6999 7000 7001 7002 7003 7004 7005 7006 7007 7008 7009 7010 7011 ... 7860